Hamza Ichaoui Sonia Ben Nasr Faten Gargouri Aref Zribi Amine Hermi Sana Fendri Mehdi Balti Jihen Ayari Ramzi Khiari Issam Msakni Nada Mansouri Samir Ghozzi Abderrazek Haddaoui
10.11604/pamj.2019.34.125.19421
Pan Afr Med J
2019 Nov 1;34:125.
prostate hormonotherapy squamous cell carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/33708294/
Adenocarcinoma / pathology Carcinoma, Squamous Cell / pathology Prostatic Neoplasms / pathology
Adenocarcinoma / pathology Carcinoma, Squamous Cell / pathology Prostatic Neoplasms / pathology Case Reports Adenocarcinoma / therapy Aged Antineoplastic Agents, Hormonal / administration & dosage Carcinoma, Squamous Cell / therapy Combined Modality Therapy Gonadotropin-Releasing Hormone / agonists Humans Male Neoplasm Recurrence, Local Prostatectomy Prostatic Neoplasms / therapy Triptorelin Pamoate / administration & dosage Antineoplastic Agents, Hormonal Triptorelin Pamoate Gonadotropin-Releasing Hormone
PMC7906544
33708294
Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment
2019